07/02/2024, 05:44 PM UTC
新型纳米复合物DOX/TPOR4@CB[7]4在临床前研究中显示出强大的抗癌特性New Nanocomplex DOX/TPOR4@CB[7]4 Shows Potent Anti-Cancer Properties in Preclinical Studies
1、研究人员开发了一种自组装的纳米复合物DOX/TPOR4@CB[7]4,用于增强神经母细胞瘤治疗中的光动力疗法和化疗的协同作用;2、该纳米复合物在体外和体内均显示出显著的抗肿瘤效果,具有高效的活性氧生成和低毒性;3、这种新颖的方法有望改善神经母细胞瘤的治疗效果。1. Researchers developed a self-assembled nanocomposite, DOX/TPOR4@CB[7]4, for enhanced synergistic photodynamic therapy and chemotherapy in neuroblastoma treatment; 2. The nanocomposite showed significant anti-tumor effects both in vitro and in vivo, with efficient ROS generation and minimal toxicity; 3. This novel approach holds promise for improving therapeutic outcomes in neuroblastoma.
---
本文由大语言模型(LLM)生成,旨在为读者提供半导体新闻内容的知识扩展(Beta)。